Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group

Research output: Contribution to journalArticle


  • Dorte Lisbet Nielsen
  • Karsten D. Bjerre
  • Erik H. Jakobsen
  • Søren Cold
  • Lars Stenbygaard
  • Peter G. Sørensen
  • Claus Kamby
  • Susanne Møller
  • Charlotte Levin Tykjaer Jörgensen
  • Michael Andersson
External organisations
  • University of Copenhagen
Original languageEnglish
Pages (from-to)4748-4754
JournalJournal of Clinical Oncology
Issue number36
Publication statusPublished - 2011
Publication categoryResearch
Externally publishedYes